Winston Kung
Director, Adynxx, Inc.
Companies
- Corbus PharmaceuticalsBoard member Aug 20, 2024 to now1
- ArriVent BioPharma, Inc.Chief financial officer Jan 25, 2024 to now2
- Janux Therapeutics, Inc.Board member Sep 22, 2022 to now3
- PMV Pharmaceuticals, Inc.Chief financial officer Sep 24, 2020 to May 15, 20234
- PMV Pharmaceuticals, Inc.Chief operating officer Sep 24, 2020 to May 15, 20234
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Janux Therapeutics, Inc. JANX11,750 shares5$195.1K at $16.60Jun 11, 2026
Corbus Pharmaceuticals CRBP12,140 shares6$53.4K at $4.40Jun 10, 2026- PMV Pharmaceuticals, Inc. PMVP10,600 shares7$13.5K at $1.27Nov 25, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Granted 5,500 shares of Janux Therapeutics, Inc.5
- Jun 10, 2026Sold 2,026 shares at $7.91 of Corbus Pharmaceuticals6
- May 19, 2026Granted 3,800 shares of Corbus Pharmaceuticals8
- Jun 11, 2025Granted 3,750 shares of Janux Therapeutics, Inc.9
- May 30, 2025Granted 4,800 shares of Corbus Pharmaceuticals10
- Aug 16, 2024Granted 5,566 shares of Corbus Pharmaceuticals11
- Jun 26, 2024Granted 2,500 shares of Janux Therapeutics, Inc.12
- Nov 25, 2022Gift 2,560 shares of PMV Pharmaceuticals, Inc.7
- Apr 20, 2022Exercised options 4,000 shares at $3.22 of PMV Pharmaceuticals, Inc.13
- Dec 30, 2021Gift 2,725 shares of PMV Pharmaceuticals, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCorbus Pharmaceuticals, Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed May 21, 2026
- 9SEC EDGARForm 4 filed Jun 13, 2025
- 10SEC EDGARForm 4 filed Jun 2, 2025
- 11SEC EDGARForm 4 filed Aug 20, 2024
- 12SEC EDGARForm 4 filed Jun 28, 2024
- 13SEC EDGARForm 4 filed Apr 21, 2022
- 14SEC EDGARForm 4 filed Feb 8, 2022